Free shipping on all orders over $ 500

A-395

Cat. No. M11244

All AbMole products are for research use only, cannot be used for human consumption.

A-395  Structure
Size Price Availability Quantity
5mg USD 850 In stock
10mg USD 1350 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

A-395 is A Polycomb inhibitory complex 2 (Polycomb repressive complex 2; PRC2), a protein-protein interaction antagonist, inhibits the trimer PRC2 complex (ezh2-EED -SUZ12) with an IC50 value of 18 nM.

Chemical Information
Molecular Weight 486.65
Formula C26H35FN4O2S
CAS Number 2089148-72-9
Solubility (25°C) DMSO ≥ 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Yuning Li, et al. Nanotechnology. Monolayer MoS 2 photodetectors with a buried-gate field-effect transistor structure

[2] Anne-Marie W Turner, et al. ACS Infect Dis. Evaluation of EED Inhibitors as a Class of PRC2-Targeted Small Molecules for HIV Latency Reversal

[3] Esma Hande Alici, et al. Int J Biol Macromol. A novel serine protease from strawberry (Fragaria ananassa): Purification and biochemical characterization

[4] Yupeng He, et al. Nat Chem Biol. Erratum: The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex

[5] Yupeng He, et al. Nat Chem Biol. The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex

Related PRC2/EED Products
EED226

EED226 is an effective, selective and orally active Polycomb reactive complex 2 (PRC2) inhibitor. When h3k27me0 peptide is used as substrate, ic50=23.4 nm; With mononucleosome as substrate, ic50=53.5 nm. It is a first in class, effective, orally bioavailable inhibitor of embryonic ectodermal development (EED) with strong anticancer effect.

MAK683

MAK-683 is a potent inhibitor of embryonic ectoderm development protein (EED) and allosteric inhibitor of polycomb repressive complex 2 (PRC2).

ORIC-944

ORIC-944 is a selective, orally active, allosteric inhibitor targeting the EED subunit of polycomb repressive complex 2 (PRC2). ORIC-944 is synergistic with androgen receptor pathway inhibitors (ARPIs) for the study of metastatic prostate cancer.

  Catalog
Abmole Inhibitor Catalog




Keywords: A-395 supplier, PRC2/EED, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.